StonvexLoading…
StonvexStonvexStonvexCore line items from FRSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $228.63M | $838.81M | $616.07M | $400.95M |
Operating Income | $-8.06M | $13.21M | $-26.53M | $-19.07M |
Net Income | $-4.81M | $183.72M | $-7.72M | $-3.04M |
EPS (Diluted) | $-0.02 | $0.63 | $-0.03 | $-0.01 |
Total Assets | $1.61B | $1.60B | $1.37B | $1.48B |
Total Liabilities | $586.18M | $570.06M | $520.47M | $496.18M |
Cash & Equivalents | $548.17M | $569.77M | $420.93M | $485.97M |
Free Cash Flow OCF − CapEx | $58.49M | $236.67M | $176.57M | $114.89M |
Shares Outstanding | 283.34M | 293.77M | 293.88M | 297.84M |